FROM A-LEVELS OR AN OVERSEAS DEGREE TO PRACTISING IN THE UKSearch the guide
← All news
NEW MEDICINES AND DRUG DISCOVERY · SCIENCE TRANSLATIONAL MEDICINE · 21 October 2026

The kinase inhibitor dabrafenib halts progression of cerebral cavernous malformations in a BRAF-independent manner

More in New medicines and drug discovery

FDA: drugs · 23 Oct 2026October 30, 2026: Dermatologic and Ophthalmic Drugs Advisory Committee Meeting Announcement - 10/30/2026
FDA: drugs · 23 Oct 2026FDA Rare Disease Day 2027 - 03/05/2027
FDA: drugs · 23 Oct 2026GDUFA Paid Facilities List